These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 23906582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Santrůcek J, Klener P, Dyr JE.
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R, Suttnar J, Cápová I, Hrachovinová I, Urbánková M, Dyr JE.
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [Abstract] [Full Text] [Related]

  • 4. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H, Le Querrec A, de Moerloose P, Gandon-Laloum S, Borel Derlon A, Neerman-Arbez M.
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [Abstract] [Full Text] [Related]

  • 5. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F.
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
    Asselta R, Robusto M, Platé M, Santoro C, Peyvandi F, Duga S.
    Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
    Kotlín R, Reicheltová Z, Suttnar J, Salaj P, Hrachovinová I, Riedel T, Malý M, Oravec M, Kvasnicka J, Dyr JE.
    J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
    [Abstract] [Full Text] [Related]

  • 18. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
    Castaman G, Giacomelli SH, Duga S, Rodeghiero F.
    Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes.
    Simsek I, de Mazancourt P, Horellou MH, Erdem H, Pay S, Dinc A, Samama MM.
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):247-53. PubMed ID: 18388508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.